My Personal View: The Current Status of Hepatic Tumor Therapy in China
MOJ Surgery · 2014
DOI: 10.15406/mojs.2014.01.00003 ↗Kurz gefasst
Fachartikel in der Zeitschrift MOJ Surgery, 2014. Verfasst von Cheng Zhou.
Abstract (Originalsprache)
As a visiting surgeon or post graduated trainee, I was practiced and worked in several institutes of China and Europe.Most of the trainings and research projects aimed the specialty of liver tumor therapy.Those educations along with the accumulation of experiences from long time clinical practice contribute to my personal understanding for the currently status of hepatic cancer treatment in china.China is a country with high prevalence of Hepatitis B. In reports, the patients infected with hepatic virus B is about 20%.And different form western countries, amounts of liver cancer patients are results from HBV infection, while most of them with severe hepatic cirrhosis and even hepatic function decompensation.Another problem is, in china, the public routine screening is short of, and citizens are lack of educations
Zitieren
APA
Zhou, C. (2014). My Personal View: The Current Status of Hepatic Tumor Therapy in China. MOJ Surgery. https://doi.org/10.15406/mojs.2014.01.00003
Vancouver
Zhou C. My Personal View: The Current Status of Hepatic Tumor Therapy in China. MOJ Surgery. 2014. doi:10.15406/mojs.2014.01.00003
BibTeX
@article{Zhou2014,
author = {Zhou, Cheng},
title = {My Personal View: The Current Status of Hepatic Tumor Therapy in China},
journal = {MOJ Surgery},
year = {2014},
doi = {10.15406/mojs.2014.01.00003}
}
EUVIMED